Skip to main content
OpenTrials
Completed

NCT Number: NCT04328376

Measurement of the Electromechanical Window to Improve the Diagnosis of Congenital Long QT Syndrome

The goal of this research is to prospectively evaluate the performance of the electromechanical window according to a phonographic method, as a mean of diagnosis of long QT syndrome, and to compare its performance with routine tests used.

Completed

Looking for future studies?

Notify Me

Key information

Age range

12 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Nantes University Hospital, Nantes, France

Loading trial locations.

About this study

Familial long QT syndrome (LQTS) is a hereditary cardiac disorder in which most affected family members have delayed ventricular repolarization manifest on the electrocardiogram (ECG) as QT prolongation. This disease is associated with an increased propensity to palpitations, syncope, polymorphous ventricular tachycardia and sudden arrhythmic death. The diagnosis relies mostly on resting ECG findings and on genetic testing. In clinical practice however, this diagnosis is complicated by 2 main reasons: 1) a significant overlap in ECG findings between healthy and diseased individuals and 2) a frequent identification of genetic variants of unknown significance. Recent studies have suggested that echocardiographic measurement of the electromechanical window (EMW - the delay between the end of mechanical contraction and electrical activation of the heart) has better performance in the diagnosis of LQTS. The echocardiographic technique is however too complicated for routine clinical use. Preliminary work conducted at the University Hospital of Bordeaux and at the University Hospital of Reunion Island has demonstrated that a phonocardiographic approach leads to similar results with an improved feasibility and a good reproducibility.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Propositus patients with genetically proven LQTS and their relatives,
  • Patients of both sexes aged 12 and over,
  • Free, informed and written consent of the patient and the two holders of parental authority for minors.

Exclusion criteria

  • Inability to consent,
  • Person deprived of liberty by judicial or administrative decision,
  • Majors subject to a legal protection measure,
  • Person participating in another research including an exclusion period still in progress,
  • Severely impaired physical and / or psychological health, which, according to the investigator, may affect the participant's compliance with the study.

Treatment and study plan

ECG coupled to phonocardiography

Diagnostic Test

A standard ECG is recorded along with a phonocardiographic recording. The phonocardiographic recording is obtained by using a specific electronic stethoscope plugged into the auxiliary port of the ECG machine. The recording takes less than 30 seconds. The two recording methods are concomitant.

QT interval is measured on the ECG recording, EMW is measured with ECG coupled to phonocardiography.

Primary outcomes

  1. Negative predictive value (NPV) obtained by the two methods of diagnosis

    Time frame: Day 1

    The NPV is measured in percentage. The NPV of LQTS diagnosis obtained by phonocardiographic method (measurement of the EMW) and the NPV obtained by standard ECG method (QT measurement prolongation) will be compared.

Secondary outcomes

  1. Values of sensitivity obtained by the two methods of diagnosis

    Time frame: Day 1

    Value of sensitivity is measured in percentage. The values of sensitivity of EMW and standard ECG will be compared.

  2. Values of specificity obtained by the two methods of diagnosis

    Time frame: Day 1

    Value of specificity is measured in percentage. The values of specificity of EMW and standard ECG will be compared.

  3. Positive predictive values obtained by the two methods of diagnosis

    Time frame: Day 1

    Positive predictive value is measured in percentage. Positive predictive values of EMW and standard ECG will be compared.

  4. Area Under the Curves (AUC) obtained by the two methods of diagnosis

    Time frame: Day 1

    The AUC obtained by Receiver Operating Characteristic (ROC) analyses is measured by a value between 0 and 1.

    The AUC obtained by ROC of EMW and standard ECG will be compared.

Sponsors and collaborators

Lead sponsor

University Hospital, Bordeaux

Other

Registry information

Acronym: FEMQT

Important dates

Study start
2020
Primary completion
2024
Study completion
2024
First posted
Mar 31, 2020
Registry last updated
Jun 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.